Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot
This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2023-12-17 |
Generated Narrative: EvidenceVariable
Resource EvidenceVariable "179689" Version "4" Updated "2023-12-04 15:43:55+0000"
Profile: GroupAssignment
EvidenceVariableDefinition: Defined in handling and category elements (Evidence Based Medicine on FHIR Implementation Guide Code System#defined-in-handling-and-category)
StructureDefinition Work Group: cds
url: https://fevir.net/resources/EvidenceVariable/179689
identifier: FEvIR Object Identifier: 179689
version: 1.0.0-ballot
name: GroupAssignment_high_dose_xanomeline_vs_low_dose_xanomeline_vs_placebo
title: GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo
status: active
date: 2023-12-17 16:55:23+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description: This example of a GroupAssignment Profile describes a 3-arm trial (so handling='polychotomous') and lists the 3 trial arms in category.name elements. Because the definition of this EvidenceVariable Resource is fully expressed in the handling and category elements, the defintion.concept element uses a CodeableConcept for 'Defined in handling and category elements'.
| Code | Value[x] |
| Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication') | GroupAssignment (Evidence Based Medicine on FHIR Implementation Guide Code System#GroupAssignment) |
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Brian S. Alper:
| Type | Citation |
| cite-as | GroupAssignment: high dose xanomeline vs. low dose xanomeline vs. placebo [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179689. Revised 2023-12-01. Available at: https://fevir.net/resources/EvidenceVariable/179689. Computable resource at: https://fevir.net/resources/EvidenceVariable/179689. |
handling: polychotomous
category
name: high dose xanomeline
category
name: low dose xanomeline
category
name: placebo
IG © 2022+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-17
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change